cited_by cdi_FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3
cites cdi_FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3
container_end_page 1925
container_issue 16
container_start_page 1918
container_title Circulation (New York, N.Y.)
container_volume 109
creator TWICKLER, T. B
DALLINGA-THIE, G. M
COHN, J. S
CHAPMAN, M. J
description
doi_str_mv 10.1161/01.CIR.0000125278.58527.F3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71878626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71878626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3</originalsourceid><addsrcrecordid>eNpNkVFvFCEQgImxsWf1LxhiYt92u8DuwvatufS0SRMTo8-EZQcP5WAFzqTxz3e0l1QemMB8M8AHIe9Z1zI2squOtdu7L22Hg_GBS9UOCkO7Ey_Ihg28b_pBTC_JBoGpkYLzc_K6lB-4HIUcXpFzNjAm1cg25M9tgN-mwkIzHKKJtQn-J9DV5OptAGr3KUCpkFOgNkULsWZTfYrX9AaTJhuLSV-Qpg5MPWagydG6B2pwyuk7REwFv6Y1pwo-0nUPMdWHFd6QM2dCgbeneEG-7W6_bj81958_3m1v7hsrlKrN1Jt5kMviOjY45_pRCgUcrAQJth9mbiwss5KWz0LMgosJtxcn-qWfrGBGXJDLp754g19HfI0--GIhBBMhHYuWTKEMPiJ4_QTanErJ4PSa_cHkB806_Ve97phG9fpZvf6nXu8EFr87nXKcD7A8l55cI_DhBJhiTXDZROvLf5zCv-NCPAJBmZER</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71878626</pqid></control><display><type>article</type><title>Elevated remnant-like particle cholesterol concentration: A characteristic feature of the atherogenic lipoprotein phenotype</title><source>EZB Electronic Journals Library</source><creator>TWICKLER, T. B ; DALLINGA-THIE, G. M ; COHN, J. S ; CHAPMAN, M. J</creator><creatorcontrib>TWICKLER, T. B ; DALLINGA-THIE, G. M ; COHN, J. S ; CHAPMAN, M. J</creatorcontrib><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.0000125278.58527.F3</identifier><identifier>PMID: 15117861</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Arteriosclerosis - diagnosis ; Arteriosclerosis - etiology ; Biological and medical sciences ; Biomarkers - blood ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cholesterol - blood ; Cholesterol - chemistry ; Cholesterol - physiology ; Coronary Disease - diagnosis ; Coronary Disease - etiology ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Hyperlipidemias - blood ; Hyperlipidemias - drug therapy ; Hypolipidemic Agents - therapeutic use ; Lipoproteins - blood ; Lipoproteins - chemistry ; Lipoproteins - physiology ; Medical sciences ; Phenotype ; Risk Factors ; Triglycerides - blood ; Triglycerides - chemistry ; Triglycerides - physiology</subject><ispartof>Circulation (New York, N.Y.), 2004-04, Vol.109 (16), p.1918-1925</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3</citedby><cites>FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15815223$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15117861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TWICKLER, T. B</creatorcontrib><creatorcontrib>DALLINGA-THIE, G. M</creatorcontrib><creatorcontrib>COHN, J. S</creatorcontrib><creatorcontrib>CHAPMAN, M. J</creatorcontrib><title>Elevated remnant-like particle cholesterol concentration: A characteristic feature of the atherogenic lipoprotein phenotype</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><subject>Arteriosclerosis - diagnosis</subject><subject>Arteriosclerosis - etiology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cholesterol - blood</subject><subject>Cholesterol - chemistry</subject><subject>Cholesterol - physiology</subject><subject>Coronary Disease - diagnosis</subject><subject>Coronary Disease - etiology</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Hyperlipidemias - blood</subject><subject>Hyperlipidemias - drug therapy</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Lipoproteins - blood</subject><subject>Lipoproteins - chemistry</subject><subject>Lipoproteins - physiology</subject><subject>Medical sciences</subject><subject>Phenotype</subject><subject>Risk Factors</subject><subject>Triglycerides - blood</subject><subject>Triglycerides - chemistry</subject><subject>Triglycerides - physiology</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpNkVFvFCEQgImxsWf1LxhiYt92u8DuwvatufS0SRMTo8-EZQcP5WAFzqTxz3e0l1QemMB8M8AHIe9Z1zI2squOtdu7L22Hg_GBS9UOCkO7Ey_Ihg28b_pBTC_JBoGpkYLzc_K6lB-4HIUcXpFzNjAm1cg25M9tgN-mwkIzHKKJtQn-J9DV5OptAGr3KUCpkFOgNkULsWZTfYrX9AaTJhuLSV-Qpg5MPWagydG6B2pwyuk7REwFv6Y1pwo-0nUPMdWHFd6QM2dCgbeneEG-7W6_bj81958_3m1v7hsrlKrN1Jt5kMviOjY45_pRCgUcrAQJth9mbiwss5KWz0LMgosJtxcn-qWfrGBGXJDLp754g19HfI0--GIhBBMhHYuWTKEMPiJ4_QTanErJ4PSa_cHkB806_Ve97phG9fpZvf6nXu8EFr87nXKcD7A8l55cI_DhBJhiTXDZROvLf5zCv-NCPAJBmZER</recordid><startdate>20040427</startdate><enddate>20040427</enddate><creator>TWICKLER, T. B</creator><creator>DALLINGA-THIE, G. M</creator><creator>COHN, J. S</creator><creator>CHAPMAN, M. J</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040427</creationdate><title>Elevated remnant-like particle cholesterol concentration: A characteristic feature of the atherogenic lipoprotein phenotype</title><author>TWICKLER, T. B ; DALLINGA-THIE, G. M ; COHN, J. S ; CHAPMAN, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Arteriosclerosis - diagnosis</topic><topic>Arteriosclerosis - etiology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cholesterol - blood</topic><topic>Cholesterol - chemistry</topic><topic>Cholesterol - physiology</topic><topic>Coronary Disease - diagnosis</topic><topic>Coronary Disease - etiology</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Hyperlipidemias - blood</topic><topic>Hyperlipidemias - drug therapy</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Lipoproteins - blood</topic><topic>Lipoproteins - chemistry</topic><topic>Lipoproteins - physiology</topic><topic>Medical sciences</topic><topic>Phenotype</topic><topic>Risk Factors</topic><topic>Triglycerides - blood</topic><topic>Triglycerides - chemistry</topic><topic>Triglycerides - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TWICKLER, T. B</creatorcontrib><creatorcontrib>DALLINGA-THIE, G. M</creatorcontrib><creatorcontrib>COHN, J. S</creatorcontrib><creatorcontrib>CHAPMAN, M. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TWICKLER, T. B</au><au>DALLINGA-THIE, G. M</au><au>COHN, J. S</au><au>CHAPMAN, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated remnant-like particle cholesterol concentration: A characteristic feature of the atherogenic lipoprotein phenotype</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2004-04-27</date><risdate>2004</risdate><volume>109</volume><issue>16</issue><spage>1918</spage><epage>1925</epage><pages>1918-1925</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>15117861</pmid><doi>10.1161/01.CIR.0000125278.58527.F3</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2004-04, Vol.109 (16), p.1918-1925
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_71878626
source EZB Electronic Journals Library
subjects Arteriosclerosis - diagnosis
Arteriosclerosis - etiology
Biological and medical sciences
Biomarkers - blood
Blood and lymphatic vessels
Cardiology. Vascular system
Cholesterol - blood
Cholesterol - chemistry
Cholesterol - physiology
Coronary Disease - diagnosis
Coronary Disease - etiology
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hyperlipidemias - blood
Hyperlipidemias - drug therapy
Hypolipidemic Agents - therapeutic use
Lipoproteins - blood
Lipoproteins - chemistry
Lipoproteins - physiology
Medical sciences
Phenotype
Risk Factors
Triglycerides - blood
Triglycerides - chemistry
Triglycerides - physiology
title Elevated remnant-like particle cholesterol concentration: A characteristic feature of the atherogenic lipoprotein phenotype
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A00%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20remnant-like%20particle%20cholesterol%20concentration:%20A%20characteristic%20feature%20of%20the%20atherogenic%20lipoprotein%20phenotype&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=TWICKLER,%20T.%20B&rft.date=2004-04-27&rft.volume=109&rft.issue=16&rft.spage=1918&rft.epage=1925&rft.pages=1918-1925&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.0000125278.58527.F3&rft_dat=%3Cproquest_cross%3E71878626%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c388t-94ab57ddf015fff46738e2ec7e7ec45b2acedb87c2b33b3239ec4df34d49c31a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71878626&rft_id=info:pmid/15117861&rfr_iscdi=true